Pentasa contains mesalazine (5-aminosalicylic acid), which acts locally as an anti-inflammatory agent in the gastrointestinal tract rather than as an immunosuppressive drug.
Evidence against · 2
Mesalazine in inflammatory bowel disease: a trendy topic once again?
2010 · cited by 127
Paper [0] identifies Pentasa's active ingredient as mesalazine (5-ASA), a conventional anti-inflammatory and chemopreventive agent distinct from true immunosuppressants.
See more details
More against · 1
The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape.
2023 · cited by 10
Paper [3] contrasts traditional anti-metabolite immunomodulators and targeted biologics with conventional treatments like 5-ASAs for inflammatory bowel disease.